SCHEMBL26879396

SCHEMBL26879396

Cn1c(=O)c(=O)n(C2CCN(C(=O)OC(C)(C)C)CC2)c2nc(Cl)c(Cl)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.42
OGFRL1 Q5TC84 3/20 0.42
OPRD1 P41143 2/20 0.42
PIK3CA P42336 2/20 0.42
MTOR P42345 1/20 0.42
PRKDC P78527 1/20 0.42
NPBWR1 P48145 1/20 0.42
MCHR1 Q99705 1/20 0.42
TP53 P04637 1/20 0.41
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
THRB P10828 1/20 0.40
TNF P01375 1/20 0.40
LITAF Q99732 1/20 0.40
GPR119 Q8TDV5 3/20 0.39
HCAR1 Q9BXC0 1/20 0.39
STS P08842 2/20 0.39
GPR35 Q9HC97 2/20 0.39
GPR55 Q9Y2T6 2/20 0.39
CNR1 P21554 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27101015 0.91 NPBWR1 (0.43) OPRM1OGFRL1OPRD1PIK3CAMTOR
SCHEMBL24478453 0.85 PIK3CA (0.46) OPRM1OGFRL1OPRD1PIK3CAMTOR
SCHEMBL24478649 0.85 TP53 (0.46) OPRM1OGFRL1OPRD1PIK3CAMTOR
SCHEMBL27100941 0.84 HSD11B1 (0.46) OPRM1OGFRL1OPRD1PIK3CAMTOR
SCHEMBL29712733 0.84 HSD11B1 (0.46) OPRM1OGFRL1OPRD1PIK3CAMTOR
SCHEMBL29712735 0.84 OPRM1 (0.42) OPRM1OGFRL1OPRD1PIK3CAMTOR
SCHEMBL26676700 0.84 OPRM1 (0.42) OPRM1OGFRL1OPRD1PIK3CAMTOR
SCHEMBL24478472 0.83 PIK3CA (0.43) OPRM1OGFRL1OPRD1PIK3CAMTOR
SCHEMBL29712748 0.82 PIK3CA (0.47) OPRM1OGFRL1OPRD1PIK3CAMTOR
SCHEMBL27100950 0.82 PIK3CA (0.47) OPRM1OGFRL1OPRD1PIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067645-A1 HETEROCYCLIC COMPOUND AS DIACYLGLYCEROL KINASE INHIBITOR AND USE THEREOF LG CHEM, LTD. (KR) 2024-02-29 US disclosed
WO-2023229380-A1 HETEROCYCLIC COMPOUND AS DIACYLGLYCEROL KINASE INHIBITOR AND USE THEREOF 주식회사 엘지화학 2023-11-30 WO disclosed
CN-116615199-A Heterocyclic compounds as diacylglycerol kinase inhibitors and uses thereof 株式会社LG化学 2023-08-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240067645-A1 HETEROCYCLIC COMPOUND AS DIACYLGLYCEROL KINASE INHIBITOR AND USE THEREOF DGKA, DGKB, DGKK OPRM1 3100/4885OGFRL1 2706/4885OPRD1 2238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.